Skip to main content
SpringerLink
Log in

Effects of calcium channel blockers on survival after myocardial infarction

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hugenholtz PG, Michels HR, Serruys PW, Brower RW. Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.Am J Cardiol 1981;47:763–773.

    Google Scholar 

  2. Midtbo K, Hals O. Verapamil in the treatment of hypertension.Curr Ther Res 1980;27:830–838.

    Google Scholar 

  3. Antman E, Miller J, Goldberg S, et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.N Engl J Med 1980;302:1269–1273.

    PubMed  Google Scholar 

  4. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials?Stat Med 1984;3:409–420.

    PubMed  Google Scholar 

  5. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Betablockade during and after myocardial infarction: An overview of the randomised trials.Prog Cardiovas Dis 1985;27:335–371.

    Google Scholar 

  6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease.J Natl Cancer Institute 1959;22:719–748.

    Google Scholar 

  7. Yusuf S, Furberg C. Effect of acute or chronic adminstration of calcium antagonists on mortality following myocardial infarction.J Amer Coll Cardiol 1987;9:25(A).

    Google Scholar 

  8. Crea F, Deanfield J, Crean P, Sharom M, Davies G, Maseri A. Effects of Verapamil in preventing early post-infarction angina and reinfarction.Am J Cardiol 1985;55:900–904.

    PubMed  Google Scholar 

  9. Gottlieb SO, Weiss JL, Flaherty JT, Mellits ED, Ouyang P, Gottlieb SH, Shapiro EP, Chandra N, Townsend SN, Bulkley BH, Gerstenblith G. Effect of Nifedipine on clinical course and left ventricular function in low risk acute myocardial infarction: a double-blind randomized trial.Circulation 1984;70:257(abstr).

    Google Scholar 

  10. Norwegian Nifedipine Group. Nifedipine in acute myocardial infarction. No influence on enzymatic infarct size.Circulation 1983;68:22(abstr).

    Google Scholar 

  11. Wilcox RG, Hampton JR, Banks DC. Birkhead J, Burns-Cox C, Hayes MJ, Joy M, Malcolm AD, Mather HG, Rowley JM. Trial of early nifedipine treatment in patients with suspected myocardial infarction (the TRENT study).Proceedings of the British Cardiac Society 1986;506(abstr).

  12. The Danish Study Group on Verapamil in myocardial infarction. Verapamil in acute myocardial infarction.Eur Heart J 1984;5:516–528.

    Google Scholar 

  13. Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, Young PM, Schectman K, Perryman MB, Roberts R. Diltiazem and reinfarction in patients with non-Q wave MI.NEJM;315:423–429.

  14. Muller JE, Morrison J, Stone PH, Rude RE, Rosner B, Roberts R, Pearle DL, Turi ZG, Schneider JF, Serfas DH, Tate C, Scheiner E, Sobel BE, Hennekens CH, Braunwald E. Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison.Circulation 69;1984;740–747.

    PubMed  Google Scholar 

  15. Secondary Prevention Reinfarction Nifedipine Trial (SP-RINT). Calcium antagonists in secondary prevention after acute myocardial infarction.Eur Heart J; 7 Suppl B. 51–52 + unpublished data.

  16. de Geest, Kesteloot H, Piessens J. Secondary prevention of ischemic heart disease: A long term controlled lidoflazine study.Acta Cardiol 1979: suppl 24:7–46.

    Google Scholar 

  17. Holland Interuniversity Nifedipine/metoprolol Trial (HINT) research group. Early treatment of unstable angina in the coronary care unit: A randomized, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both.Br Heart J 1986;56:400–413.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, 20892, Bethesda, Maryland, USA

    Salim Yusuf

  2. Bowman Gray School of Medicine, Winston-Salem, North Carolina

    Curt D. Furberg

Authors
  1. Salim Yusuf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Curt D. Furberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yusuf, S., Furberg, C.D. Effects of calcium channel blockers on survival after myocardial infarction. Cardiovasc Drug Ther 1, 343–344 (1987). https://doi.org/10.1007/BF02209073

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02209073

Key words

Search

Navigation